27Sep
September 2016
Cabinet Barny advised Domain Therapeutics on the conclusion of a second licensing and partnership agreement on GPCR biosensor technology with Université de Montréal, the Institute for Research in Immunology and Cancer – Commercialization of Research and McGill University.
Click here for more information.